{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:33:10Z","timestamp":1761802390745,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.canep.2021.101932","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T13:36:11Z","timestamp":1616592971000},"page":"101932","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Second primary malignancies in patients with melanoma in situ: Insights from the surveillance, epidemiology, and end results program"],"prefix":"10.1016","volume":"72","author":[{"given":"Mark B.","family":"Ulanja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryce D.","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Antwi-Amoabeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair E.","family":"Moody","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ganiyu A.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis T.","family":"Djankpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nageshwara","family":"Gullapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Killian","family":"Boampong-Konam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica K.","family":"Macaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron T.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Baral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jamadermatol.2019.3353","article-title":"Age-specific incidence of melanoma in the United States","volume":"156","author":"Paulson","year":"2020","journal-title":"JAMA Dermatol."},{"issue":"11","key":"10.1016\/j.canep.2021.101932_bib0015","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1001\/jamadermatol.2016.2668","article-title":"Detection of occult invasion in melanoma in situ","volume":"152","author":"Bax","year":"2016","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.canep.2021.101932_bib0020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2015.04.014","article-title":"Melanoma in situ: part I. Epidemiology, screening, and clinical features","volume":"73","author":"Higgins","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.canep.2021.101932_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jaad.2015.03.057","article-title":"Melanoma in situ: part II. Histopathology, treatment, and clinical management","volume":"73","author":"Higgins","year":"2015","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.canep.2021.101932_bib0030","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2016.10.018","article-title":"Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992\u20132013","volume":"76","author":"Landow","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"6","key":"10.1016\/j.canep.2021.101932_bib0035","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1634\/theoncologist.2010-0340","article-title":"Cutaneous melanoma in situ: translational evidence from a large population-based study","volume":"16","author":"Mocellin","year":"2011","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.canep.2021.101932_bib0040","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/(SICI)1097-0215(19991029)83:3<314::AID-IJC5>3.0.CO;2-9","article-title":"Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ","volume":"83","author":"Wassberg","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"5 Suppl 1","key":"10.1016\/j.canep.2021.101932_bib0045","first-page":"S69","article-title":"Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin","volume":"65","author":"Balamurugan","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"10.1016\/j.canep.2021.101932_bib0050","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jid.2018.11.001","article-title":"Risk of second primary cancer in survivors of in situ melanoma","volume":"139","author":"Kimlin","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.canep.2021.101932_bib0055","series-title":"Cancer registration: Principles and Methods. Classification and Coding of Neoplasms","first-page":"64","author":"Muir","year":"1991"},{"year":"2004","series-title":"SEER Program Coding and Staging Manual 2004, Revision 1","author":"Johnson","key":"10.1016\/j.canep.2021.101932_bib0060"},{"issue":"4 Suppl","key":"10.1016\/j.canep.2021.101932_bib0065","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/1097-0142(197710)40:4+<1892::AID-CNCR2820400820>3.0.CO;2-H","article-title":"Statistical methods for studying multiple primary malignant neoplasms","volume":"40","author":"Schoenberg","year":"1977","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.canep.2021.101932_bib0070","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a117689","article-title":"Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"142","author":"Begg","year":"1995","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.canep.2021.101932_bib0075","series-title":"Statistical Methods In Cancer Research. Volume II \u2013 the Design and Analysis of Cohort Studies","first-page":"1","author":"Breslow","year":"1987"},{"issue":"5","key":"10.1016\/j.canep.2021.101932_bib0080","first-page":"451","article-title":"The incidence of second primary invasive melanoma in Queensland, 1982\u20132003","volume":"19","author":"McCaul","year":"2008","journal-title":"Cancer Causes Control"},{"issue":"6","key":"10.1016\/j.canep.2021.101932_bib0085","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1365-2133.2012.11123.x","article-title":"Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989\u20132008","volume":"167","author":"van der Leest","year":"2012","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.canep.2021.101932_bib0090","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/archdermatol.2010.2","article-title":"Increased risk of second primary cancers after a diagnosis of melanoma","volume":"146","author":"Bradford","year":"2010","journal-title":"Arch. Dermatol."},{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/bjd.12694","article-title":"Risk of second primary malignancies following a diagnosis of cutaneous malignant melanoma or nonmelanoma skin cancer in Alberta, Canada from 1979 to 2009","volume":"170","author":"Jung","year":"2014","journal-title":"Br. J. Dermatol."},{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0100","doi-asserted-by":"crossref","first-page":"7167","DOI":"10.1038\/s41598-018-25408-6","article-title":"An initial melanoma diagnosis may increase the subsequent risk of prostate cancer: results from the New South Wales Cancer Registry","volume":"8","author":"Cole-Clark","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.canep.2021.101932_bib0105","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1111\/jdv.13645","article-title":"Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy","volume":"30","author":"Caini","year":"2016","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"6","key":"10.1016\/j.canep.2021.101932_bib0110","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1001\/jamadermatol.2014.4777","article-title":"Risk of next melanoma in patients with familial and sporadic melanoma by number of previous melanomas","volume":"151","author":"Chen","year":"2015","journal-title":"JAMA Dermatol."},{"issue":"2","key":"10.1016\/j.canep.2021.101932_bib0115","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaad.2019.08.074","article-title":"Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring","volume":"82","author":"Lallas","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0120","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.canep.2021.101932_bib0125","doi-asserted-by":"crossref","first-page":"42601","DOI":"10.1038\/srep42601","article-title":"Risk of other cancers in families with melanoma: novel familial links","volume":"7","author":"Frank","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.canep.2021.101932_bib0130","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/cncr.31175","article-title":"Telomerase reverse transcriptase promoter alterations across cancer types as detected by next-generation sequencing: a clinical and molecular analysis of 423 patients","volume":"124","author":"Schwaederle","year":"2018","journal-title":"Cancer"},{"issue":"7375","key":"10.1016\/j.canep.2021.101932_bib0135","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature10539","article-title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma","volume":"480","author":"Bertolotto","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.canep.2021.101932_bib0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3390\/nu2050482","article-title":"The relationship between ultraviolet radiation exposure and vitamin D status","volume":"2","author":"Engelsen","year":"2010","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.canep.2021.101932_bib0145","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jnci\/djy087","article-title":"Circulating vitamin D and colorectal cancer risk: an international pooling project of 17 cohorts","volume":"111","author":"McCullough","year":"2019","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0150","first-page":"211","article-title":"Vitamin D: potential in the prevention and treatment of lung cancer","volume":"32","author":"Norton","year":"2012","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.canep.2021.101932_bib0155","first-page":"1","article-title":"Vitamin D and gastrointestinal cancer","volume":"10","author":"Mahendra","year":"2018","journal-title":"J. Lab. Phys."},{"issue":"6","key":"10.1016\/j.canep.2021.101932_bib0160","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/ijc.25439","article-title":"Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma","volume":"128","author":"Gandini","year":"2011","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.canep.2021.101932_bib0165","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/jpm5030243","article-title":"Lifestyle factors in cancer survivorship: where we are and where we are headed","volume":"5","author":"Vijayvergia","year":"2015","journal-title":"J. Pers. Med."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782121000497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782121000497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:28:09Z","timestamp":1761802089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782121000497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":33,"alternative-id":["S1877782121000497"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2021.101932","relation":{},"ISSN":["1877-7821"],"issn-type":[{"type":"print","value":"1877-7821"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Second primary malignancies in patients with melanoma in situ: Insights from the surveillance, epidemiology, and end results program","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2021.101932","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101932"}}